Litcius/Paper detail

FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies

Wenyue Shen, Quanwei Zhou, Chenxi Peng, Jiaheng Li, Qizhi Yuan, Hecheng Zhu, Mingwen Zhao, Xingjun Jiang, Weidong Liu, Caiping Ren

2022Frontiers in Oncology33 citationsDOIOpen Access PDF

Abstract

FBXW7, a member of the F-box protein family within the ubiquitin-proteasome system, performs an indispensable role in orchestrating cellular processes through ubiquitination and degradation of its substrates, such as c-MYC, mTOR, MCL-1, Notch, and cyclin E. Mainly functioning as a tumor suppressor, inactivation of FBXW7 induces the aberrations of its downstream pathway, resulting in the occurrence of diseases especially tumorigenesis. Here, we decipher the relationship between FBXW7 and the hallmarks of cancer and discuss the underlying mechanisms. Considering the interplay of cancer hallmarks, we propose several prospective strategies for circumventing the deficits of therapeutic resistance and complete cure of cancer patients.

Topics & Concepts

UbiquitinCancerSuppressorCancer researchProteasomeCarcinogenesisBiologyMechanism (biology)Ubiquitin ligaseCell biologyBioinformaticsGeneticsEpistemologyGenePhilosophyUbiquitin and proteasome pathwaysAutophagy in Disease and TherapyCancer-related Molecular Pathways
FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies | Litcius